Article
Clinical application of artificial neural network (ANN) modeling to predict BRCA1/2 germline deleterious variants in Chinese bilateral primary breast cancer patients.
BMC cancer - 2 Nov 2022
Li Yan, Chen Lili, Lv Jinxing, Chen Xiaobin, Zeng Bangwei, Chen Minyan, Guo Wenhui, Lin Yuxiang, Yu Liuwen, Hou Jialin, Li Jing, Zhou Peng, Zhang Wenzhe, Li Shengmei, Jin Xuan, Cai Weifeng, Zhang Kun, Huang Yeyuan, Wang Chuan, Fu Fangmeng
Abstract excerpt
BACKGROUND: Bilateral breast cancer (BBC), as well as ovarian cancer, are significantly associated with germline deleterious variants in BRCA1/2, while BRCA1/2 germline deleterious variants carriers can exquisitely benefit from poly (ADP-ribose) polymerase (PARP) inhibitors. However, formal genetic testing could not be carried out for all patients due to extensive use of healthcare resources, which in turn...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
